Re: Efficacy and Toxicity of Sunitinib in Patients With Metastatic Renal Cell Carcinoma With Severe Renal Impairment or in Haemodialysis Editorial Comment

被引:0
|
作者
Taneja, Samir S.
机构
来源
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词
D O I
10.1016/j.juro.2011.12.129
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1223 / 1224
页数:2
相关论文
共 50 条
  • [1] EFFICACY AND TOXICITY OF SUNITINIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA WITH SEVERE RENAL IMPAIRMENT OR ON HAEMODIALYSIS
    O'Donnell, Peter H.
    BJU INTERNATIONAL, 2011, 108 (08) : 1284 - 1285
  • [2] Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma (mRCC) with severe renal impairment or on haemodialysis
    Josephs, D. H.
    Hutson, T. E.
    Pickering, L. M.
    Larkin, J. M.
    Choueiri, T. K.
    Patel, T. V.
    Mcdermott, D. F.
    Powles, T.
    Harper, P. G.
    Chowdhury, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency
    Kim, Ki Hyang
    Kim, Ho Young
    Kim, Hye Ryun
    Sun, Jong-Mu
    Lim, Ho Yeong
    Lee, Hyo Jin
    Lee, Suee
    Bae, Woo Kyun
    Rha, Sun Young
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (04) : 746 - 752
  • [4] Efficacy and toxicity of sunitinib in renal insufficiency patients with metastatic renal cell carcinoma.
    Kim, Ki Hyang
    Rha, Sun Young
    Kim, Ho Young
    Kim, Hye Ryun
    Sun, Jong-Mu
    Lim, Ho Yeong
    Lee, Hyo Jin
    Lee, Suee
    Bae, Woo Kyun
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Efficacy and Toxicity of Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Birmingham Experience
    Ansari, J.
    Fatima, A.
    Fernando, K.
    Collins, S.
    James, N. D.
    Porfiri, E.
    CLINICAL ONCOLOGY, 2009, 21 (01) : 68 - 68
  • [6] Re: Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
    van den Meiracker, Anton H.
    Danser, A. H. Jan
    Sleijfer, Stefan
    Kappers, Mariette H. W.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (20) : 1557 - 1557
  • [7] Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency
    Poprach, Alexandr
    Bortlicek, Zbynek
    Melichar, Bohuslav
    Lakomy, Radek
    Svoboda, Marek
    Kiss, Igor
    Zemanova, Milada
    Fiala, Ondrej
    Kubackova, Katerina
    Coufal, Oldrich
    Pavlik, Tomas
    Dusek, Ladislav
    Vyzula, Rostislav
    Buchler, Tomas
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (04) : 507 - 513
  • [8] Sorafenib in Patients With Metastatic Renal Cell Carcinoma Refractory to Either Sunitinib or Bevacizumab Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2011, 185 (03): : 809 - 809
  • [9] Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Editorial Comment
    Marshall, Fray F.
    JOURNAL OF UROLOGY, 2010, 184 (04): : 1303 - 1303
  • [10] Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    Schmidinger, Manuela
    Zielinski, Christoph C.
    Vogl, Ursula M.
    Bojic, Andja
    Bojic, Marija
    Schukro, Christoph
    Ruhsam, Marquerite
    Hejna, Michael
    Schmidinger, Herwig
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) : 5204 - 5212